In this video, experts highlight early intensive glycemic control, HbA1c/CGM targets, and legacy-effect prevention, including evidence for SGLT2, GLP-1, and gliclazide MR.
Prof. Antonio Ceriello – Head of Diabetes Department – IRCCS Multimedica, Milan, Italia
Prof. Jeyakantha Ratnasingam – Head of Endocrinology – UMMC, Kuala Lumpur, Malaysia
Prof. Patrice Francis-Emmanuel – Endocrinologist – University of the West Indies, Mona Kingston, Jamaica
Watch the full video to learn more!
Content exclusive for connected users. Please sign in or register to access more.
Already have an account?
Sign inNew here?
Create account
